CD8A and neoplasm: More incredibly, the ferroptosis inducers, RSL3 and IKE, significant attract CD8+ T cell ferroptosis but inhibit CD8+ T cell proliferation and function, thus increasing tumor progression in immunocompetent mice [7,8,38,39].